Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans

M. J. Pirwitz, J. E. Willard, C. Landau, R. A. Lange, D. B. Glamann, D. J. Kessler, E. H. Foerster, E. Todd, L. D. Hillis

Research output: Contribution to journalArticle

25 Citations (Scopus)

Abstract

Background: Cocaine and ethanol are often abused concomitantly, and this combination may be more lethal than either substance alone. Although previous studies showed that cocaine causes coronary arterial vasoconstriction, the combined effect of cocaine and ethanol on the coronary vasculature in humans is unknown. Thus, we assessed the effects of intranasal cocaine, intravenous ethanol, or a cocaine-ethanol combination on heart rate, systemic arterial pressure, and coronary arterial dimensions in humans. Methods: Thirty-four subjects with chest pain (27 men and seven women, aged 34 to 67 years) who were referred for catheterization received one of the following pharmacologic interventions: (1) intranasal (2 mL) and intravenous (5 mL/kg) saline (n=8 [group A]); (2) intranasal cocaine (2 mg/kg) and intravenous saline (5 mL/kg) (n=9 [group B]); (3) intranasal saline (2 mL) and intravenous 10% ethanol (5 mL/kg) (n=9 [group C]); or (4) intranasal cocaine (2 mg/kg) and intravenous 10% ethanol (5 mL/kg) (n=8 [group D]). Heart rate, systemic arterial pressure, left coronary arterial dimensions (by computer-assisted quantitative angiography), as well as blood cocaine, ethanol, and cocaine metabolite concentrations were measured before and 30, 60, and 90 minutes after initiation of the intravenous infusions. Results: No hemodynamic or angiographic changes were observed in the group A (saline) subjects. In the group B (cocaine) subjects, the heart rate-systolic arterial pressure product increased by 5% and 10% at 30 and 90 minutes, respectively, and coronary arterial diameter decreased by 14% at these times. In the group C (ethanol) subjects, no hemodynamic changes were noted, but coronary arterial diameters increased by 12%, 11% and 12% at 30, 60, and 90 minutes, respectively. In the group D (cocaine-ethanol) patients, rate-pressure product increased by 17%, 10%, and 16%, and coronary arterial diameters increased by 7%, 12%, and 13%, at 30, 60, and 90 minutes, respectively. Conclusion: The combination of intranasal cocaine and intravenous ethanol causes an increase in the determinants of myocardial oxygen demand. However, it also causes a concomitant increase in epicardial coronary arterial diameter.

Original languageEnglish (US)
Pages (from-to)1186-1191
Number of pages6
JournalArchives of Internal Medicine
Volume155
Issue number11
StatePublished - 1995

Fingerprint

Cocaine
Ethanol
Arterial Pressure
Heart Rate
Hemodynamics
Vasoconstriction
Chest Pain
Intravenous Infusions
Catheterization
Angiography
Oxygen
Blood Pressure
Pressure

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Pirwitz, M. J., Willard, J. E., Landau, C., Lange, R. A., Glamann, D. B., Kessler, D. J., ... Hillis, L. D. (1995). Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans. Archives of Internal Medicine, 155(11), 1186-1191.

Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans. / Pirwitz, M. J.; Willard, J. E.; Landau, C.; Lange, R. A.; Glamann, D. B.; Kessler, D. J.; Foerster, E. H.; Todd, E.; Hillis, L. D.

In: Archives of Internal Medicine, Vol. 155, No. 11, 1995, p. 1186-1191.

Research output: Contribution to journalArticle

Pirwitz, MJ, Willard, JE, Landau, C, Lange, RA, Glamann, DB, Kessler, DJ, Foerster, EH, Todd, E & Hillis, LD 1995, 'Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans', Archives of Internal Medicine, vol. 155, no. 11, pp. 1186-1191.
Pirwitz MJ, Willard JE, Landau C, Lange RA, Glamann DB, Kessler DJ et al. Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans. Archives of Internal Medicine. 1995;155(11):1186-1191.
Pirwitz, M. J. ; Willard, J. E. ; Landau, C. ; Lange, R. A. ; Glamann, D. B. ; Kessler, D. J. ; Foerster, E. H. ; Todd, E. ; Hillis, L. D. / Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans. In: Archives of Internal Medicine. 1995 ; Vol. 155, No. 11. pp. 1186-1191.
@article{37796dbf5a9840d9bdcb0aaf6c29a74d,
title = "Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans",
abstract = "Background: Cocaine and ethanol are often abused concomitantly, and this combination may be more lethal than either substance alone. Although previous studies showed that cocaine causes coronary arterial vasoconstriction, the combined effect of cocaine and ethanol on the coronary vasculature in humans is unknown. Thus, we assessed the effects of intranasal cocaine, intravenous ethanol, or a cocaine-ethanol combination on heart rate, systemic arterial pressure, and coronary arterial dimensions in humans. Methods: Thirty-four subjects with chest pain (27 men and seven women, aged 34 to 67 years) who were referred for catheterization received one of the following pharmacologic interventions: (1) intranasal (2 mL) and intravenous (5 mL/kg) saline (n=8 [group A]); (2) intranasal cocaine (2 mg/kg) and intravenous saline (5 mL/kg) (n=9 [group B]); (3) intranasal saline (2 mL) and intravenous 10{\%} ethanol (5 mL/kg) (n=9 [group C]); or (4) intranasal cocaine (2 mg/kg) and intravenous 10{\%} ethanol (5 mL/kg) (n=8 [group D]). Heart rate, systemic arterial pressure, left coronary arterial dimensions (by computer-assisted quantitative angiography), as well as blood cocaine, ethanol, and cocaine metabolite concentrations were measured before and 30, 60, and 90 minutes after initiation of the intravenous infusions. Results: No hemodynamic or angiographic changes were observed in the group A (saline) subjects. In the group B (cocaine) subjects, the heart rate-systolic arterial pressure product increased by 5{\%} and 10{\%} at 30 and 90 minutes, respectively, and coronary arterial diameter decreased by 14{\%} at these times. In the group C (ethanol) subjects, no hemodynamic changes were noted, but coronary arterial diameters increased by 12{\%}, 11{\%} and 12{\%} at 30, 60, and 90 minutes, respectively. In the group D (cocaine-ethanol) patients, rate-pressure product increased by 17{\%}, 10{\%}, and 16{\%}, and coronary arterial diameters increased by 7{\%}, 12{\%}, and 13{\%}, at 30, 60, and 90 minutes, respectively. Conclusion: The combination of intranasal cocaine and intravenous ethanol causes an increase in the determinants of myocardial oxygen demand. However, it also causes a concomitant increase in epicardial coronary arterial diameter.",
author = "Pirwitz, {M. J.} and Willard, {J. E.} and C. Landau and Lange, {R. A.} and Glamann, {D. B.} and Kessler, {D. J.} and Foerster, {E. H.} and E. Todd and Hillis, {L. D.}",
year = "1995",
language = "English (US)",
volume = "155",
pages = "1186--1191",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "11",

}

TY - JOUR

T1 - Influence of cocaine, ethanol, or their combination on epicardial coronary arterial dimensions in humans

AU - Pirwitz, M. J.

AU - Willard, J. E.

AU - Landau, C.

AU - Lange, R. A.

AU - Glamann, D. B.

AU - Kessler, D. J.

AU - Foerster, E. H.

AU - Todd, E.

AU - Hillis, L. D.

PY - 1995

Y1 - 1995

N2 - Background: Cocaine and ethanol are often abused concomitantly, and this combination may be more lethal than either substance alone. Although previous studies showed that cocaine causes coronary arterial vasoconstriction, the combined effect of cocaine and ethanol on the coronary vasculature in humans is unknown. Thus, we assessed the effects of intranasal cocaine, intravenous ethanol, or a cocaine-ethanol combination on heart rate, systemic arterial pressure, and coronary arterial dimensions in humans. Methods: Thirty-four subjects with chest pain (27 men and seven women, aged 34 to 67 years) who were referred for catheterization received one of the following pharmacologic interventions: (1) intranasal (2 mL) and intravenous (5 mL/kg) saline (n=8 [group A]); (2) intranasal cocaine (2 mg/kg) and intravenous saline (5 mL/kg) (n=9 [group B]); (3) intranasal saline (2 mL) and intravenous 10% ethanol (5 mL/kg) (n=9 [group C]); or (4) intranasal cocaine (2 mg/kg) and intravenous 10% ethanol (5 mL/kg) (n=8 [group D]). Heart rate, systemic arterial pressure, left coronary arterial dimensions (by computer-assisted quantitative angiography), as well as blood cocaine, ethanol, and cocaine metabolite concentrations were measured before and 30, 60, and 90 minutes after initiation of the intravenous infusions. Results: No hemodynamic or angiographic changes were observed in the group A (saline) subjects. In the group B (cocaine) subjects, the heart rate-systolic arterial pressure product increased by 5% and 10% at 30 and 90 minutes, respectively, and coronary arterial diameter decreased by 14% at these times. In the group C (ethanol) subjects, no hemodynamic changes were noted, but coronary arterial diameters increased by 12%, 11% and 12% at 30, 60, and 90 minutes, respectively. In the group D (cocaine-ethanol) patients, rate-pressure product increased by 17%, 10%, and 16%, and coronary arterial diameters increased by 7%, 12%, and 13%, at 30, 60, and 90 minutes, respectively. Conclusion: The combination of intranasal cocaine and intravenous ethanol causes an increase in the determinants of myocardial oxygen demand. However, it also causes a concomitant increase in epicardial coronary arterial diameter.

AB - Background: Cocaine and ethanol are often abused concomitantly, and this combination may be more lethal than either substance alone. Although previous studies showed that cocaine causes coronary arterial vasoconstriction, the combined effect of cocaine and ethanol on the coronary vasculature in humans is unknown. Thus, we assessed the effects of intranasal cocaine, intravenous ethanol, or a cocaine-ethanol combination on heart rate, systemic arterial pressure, and coronary arterial dimensions in humans. Methods: Thirty-four subjects with chest pain (27 men and seven women, aged 34 to 67 years) who were referred for catheterization received one of the following pharmacologic interventions: (1) intranasal (2 mL) and intravenous (5 mL/kg) saline (n=8 [group A]); (2) intranasal cocaine (2 mg/kg) and intravenous saline (5 mL/kg) (n=9 [group B]); (3) intranasal saline (2 mL) and intravenous 10% ethanol (5 mL/kg) (n=9 [group C]); or (4) intranasal cocaine (2 mg/kg) and intravenous 10% ethanol (5 mL/kg) (n=8 [group D]). Heart rate, systemic arterial pressure, left coronary arterial dimensions (by computer-assisted quantitative angiography), as well as blood cocaine, ethanol, and cocaine metabolite concentrations were measured before and 30, 60, and 90 minutes after initiation of the intravenous infusions. Results: No hemodynamic or angiographic changes were observed in the group A (saline) subjects. In the group B (cocaine) subjects, the heart rate-systolic arterial pressure product increased by 5% and 10% at 30 and 90 minutes, respectively, and coronary arterial diameter decreased by 14% at these times. In the group C (ethanol) subjects, no hemodynamic changes were noted, but coronary arterial diameters increased by 12%, 11% and 12% at 30, 60, and 90 minutes, respectively. In the group D (cocaine-ethanol) patients, rate-pressure product increased by 17%, 10%, and 16%, and coronary arterial diameters increased by 7%, 12%, and 13%, at 30, 60, and 90 minutes, respectively. Conclusion: The combination of intranasal cocaine and intravenous ethanol causes an increase in the determinants of myocardial oxygen demand. However, it also causes a concomitant increase in epicardial coronary arterial diameter.

UR - http://www.scopus.com/inward/record.url?scp=0029062065&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029062065&partnerID=8YFLogxK

M3 - Article

VL - 155

SP - 1186

EP - 1191

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 11

ER -